Coefficient of Variation for Hemoglobin A1c Results That Are Traceable to National Glycohemoglobin Standardization Program Must Be Distinguished from Coefficient of Variation for Results Traceable to International Federation of Clinical Chemistry and Laboratory Medicine

2011 ◽  
Vol 13 (12) ◽  
pp. 1271-1272 ◽  
Author(s):  
Gunnar Nordin
Keyword(s):  
Coefficient Of Variation ◽  
Hemoglobin A1c ◽  
Clinical Chemistry ◽  
Laboratory Medicine ◽  
International Federation

scholarly journals Glycated hemoglobin a1c as a modern biochemical marker of glucose regulation

2014 ◽  
Vol 67 (9-10) ◽  
pp. 339-344 ◽  
Author(s):  
Suncica Kojic-Damjanov ◽  
Mirjana Djeric ◽  
Nevena Eremic-Kojic
Keyword(s):  
Blood Glucose ◽  
Hemoglobin A1c ◽  
Glycated Hemoglobin ◽  
Clinical Chemistry ◽  
Microvascular Complications ◽  
Reference Method ◽  
Laboratory Medicine ◽  
International Federation ◽  
Glycated Hemoglobin A1c ◽  
Diagnostic Criterion

Glycated Hemoglobin Structure and Synthesis of Molecule. Glycated hemoglobin A1c, the major fraction of glycated hemoglobin, is formed by irreversible nonenzymatic glycation. Its concentration depends only on the life span of red blood cells and blood glucose levels. Clinical Significance of Glycated Hemoglobin A1c. It is the key parameter for monitoring the regulation of diabetes and for assessing the risk of microvascular complications. It is a diagnostic criterion for diabetes as well. Its concentration reflects the average value of blood glucose over the last two to three months. The estimated average glucose, a new parameter which facilitates the patient?s self-monitoring of diabetes, can be calculated from its value. Methods for Determining Glycated Hemoglobin A1c and their Standardization. Immunoassay and ion-exchange chromatography are commonly used methods for the glycated hemoglobin determination in routine laboratory practice. The advantage of immunoassay is that there is no need for the sample pretreatment in order to eliminate unstable glycated hemoglobin A1c intermediary forms, and the possibility of false positive results is lower. The current program of standardization requires traceability to the International Federation of Clinical Chemistry and Laboratory Medicine reference method. Reporting and Interpretation of Results of Glycated Hemoglobin A1c Determination. Glycated Hemoglobin A1c can be reported as % or as mmol/mol. In our country, it is recommended to use the International Federation of Clinical Chemistry and Laboratory Medicine units (mmol/mol). When interpreting the results, the potential causes of falsely high or low values must always be taken into consideration. Recommendations for Clinical Practice. Periodic determinations of glycated hemoglobin A1c are recommended for monitoring of diabetes regulation. Additionally, the determination is recommended for the diagnosis of diabetes. The target value for the prevention of microvascular complications is < 7% and the diagnostic criterion for diabetes is ? 6.5%.

A reference material for traceability of aspartate aminotransferase (AST) results

2005 ◽  
Vol 43 (5) ◽  
Author(s):  
Georges Férard ◽  
Françoise Imbert-Bismut ◽  
Djamila Messous ◽  
Annie Piton ◽  
Shigeru Ueda ◽  
...  
Keyword(s):  
Reference Material ◽  
Viral Hepatitis ◽  
Coefficient Of Variation ◽  
Aspartate Aminotransferase ◽  
Clinical Chemistry ◽  
Laboratory Medicine ◽  
International Federation ◽  
Mean Values ◽  
Reference Procedure ◽  
Primary Reference

AbstractStandardization of aspartate aminotransferase (AST) determination is highly desirable for inter-laboratory comparison. Serum AST mean values for 20 patients suffering from viral hepatitis showed an inter-laboratory (n=13) variation of 9.4%. Part of this variation was due to two laboratories using procedures without pyridoxal-5′-phosphate. A traceable AST value was assigned to an enzyme calibrator (EC) through the appropriate International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) primary reference procedure. The EC was commutable for seven routine methods. Common calibration using the EC reduced the inter-laboratory coefficient of variation (CV=5.9%

scholarly journals High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers

2019 ◽  
Vol 57 (5) ◽  
pp. 623-632 ◽  
Author(s):  
Paul O. Collinson ◽  
Amy K. Saenger ◽  
Fred S. Apple ◽  
Keyword(s):  
Cardiac Troponin ◽  
Task Force ◽  
Clinical Chemistry ◽  
Point Of Care ◽  
High Sensitivity ◽  
Laboratory Medicine ◽  
International Federation ◽  
Cardiac Biomarkers ◽  
Educational Materials ◽  
Extensive Information

AbstractThe International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) formed a Task Force on the Application of Cardiac Bio-markers (TF-CB) in 2008, re-designated in 2018 as a committee (C-CB), to produce educational materials on cardiac biomarkers. Established in June 2017, definitive tables covering the majority of high-sensitivity, contemporary and point-of-care (POC) cTn assays have been developed by the C-CB and are available on the IFCC website. These tables provide extensive information about assays’ analytical characteristics and encompass information on diagnostic discriminants, particularly the 99th percentiles, as provided by the manufacturers.

Referenzbereiche von Insulin, insulinähnlichem Wachstumsfaktor 1 (IGF-1) und adrenokortikotropem Hormon bei Ponys

2016 ◽  
Vol 44 (01) ◽  
pp. 19-25 ◽  
Author(s):  
G. Köller ◽  
K. Bassewitz ◽  
G. F. Schusser
Keyword(s):  
Clinical Chemistry ◽  
Laboratory Medicine ◽  
International Federation ◽  
Pars Intermedia ◽  
Klinische Relevanz

ZusammenfassungZiel dieser Arbeit war, den Einsatz des Automaten IMMULITE 2000® mit einem immunometrischen Chemolumineszenz-Assay für die Bestimmung von adrenokortikotropem Hormon (ACTH), Insulin und Insulinwachstumsfaktor 1 (IGF-1) zu prüfen und entsprechende Referenzbereiche für Ponys zu berechnen. Material und Methoden: Nachmittags gewonnene Blutproben von 130 Ponys im Alter von 3–32 Jahren wurden auf Insulin, IGF-1 und ACTH untersucht. Die Referenzbereiche wurden nach der Richtlinie EP28-A3C der International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) aus dem Jahr 2010 berechnet. Ergebnisse: Die Präzision für die Messungen an einem Tag lag für Insulin im Mittel bei 3,28%, für IGF-1 bei 1,84% und für ACTH bei 3,35%. Die Tag-zu-Tag-Präzision (Insulin: 3,45%; IGF-1: 2,89%; ACTH: 9,77%) wurde an drei aufeinanderfolgenden Tagen gemessen, wobei die Lagerung der Proben bei 4 °C erfolgte. Es zeigte sich kein signifikanter Verlust der Insulinaktivität bzw. der Konzentrationen von ACTH und IGF-1. Für Insulin und IGF-1 ergaben sich altersunabhängige Referenzbereiche (Insulin: 2,0–21,2 mU/l; IGF-1: 50,2–357,2 μg/l). Dagegen wurde für ACTH ein altersabhängiger Referenzbereich er - mittelt, der bei Ponys im Alter von 3–12 Jahren signifikant niedriger war (4,2–19,8 pg/ml) als bei Ponys im Alter von 13–32 Jahren (5,0–22,6 pg/ml). Schlussfolgerung: Das verwendete Analyseverfahren eignet sich für die Untersuchung von Serumproben von Ponys auf ACTH, IGF-1 und Insulin, doch wird der Einsatz bei der Insulinmessung durch die untere Nachweisgrenze von 2,0 mU/l limitiert. Klinische Relevanz: Die berechneten Referenzbereiche für Insulin und ACTH sind hilfreich für die Diagnostik und Verlaufskontrolle des equinen metabolischen Syndroms und der Pituitary Pars Intermedia Dysfunction (PPID).

scholarly journals Introducing the new laboratory standard of HbA1c determination in Hungary

2011 ◽  
Vol 152 (14) ◽  
pp. 555-558
Author(s):  
Gabriella Bekő
Keyword(s):  
Master Equation ◽  
Clinical Chemistry ◽  
Reference Method ◽  
Laboratory Medicine ◽  
International Federation ◽  
New Method ◽  
Interlaboratory Comparisons

A new laboratory standard, specific for HbA1c was prepared by the International Federation of Clinical Chemistry and Laboratory Medicine. Consequently, manufacturers will supply their calibrators with the International Federation of Clinical Chemistry and Laboratory Medicine standard. Laboratories in Hungary switch to this new method in April 1, 2011. After this date, results of HbA1c measurements will be reported in International Federation of Clinical Chemistry and Laboratory Medicine units (mmol/mol) and in the derived National Glycohemoglobin Standardization Program units (%) calculated by master equation from the International Federation of Clinical Chemistry and Laboratory Medicine/National Glycohemoglobin Standardization Program methods. Using the new standardization the HbA1c measurements will be traceable to the International Federation of Clinical Chemistry and Laboratory Medicine reference method and interlaboratory comparisons will be possible. Orv. Hetil., 2011, 152, 555–558.

scholarly journals Society of medical biochemists of Serbia and Montenegro: 50 years anniversary

2005 ◽  
Vol 24 (3) ◽  
pp. 157-170
Author(s):  
Nada Majkic-Singh
Keyword(s):  
Cell Biology ◽  
Clinical Biochemistry ◽  
Health Workers ◽  
International Association ◽  
Clinical Chemistry ◽  
Laboratory Medicine ◽  
Scientific Discipline ◽  
International Federation ◽  
Chemistry Laboratory ◽  
Pharmaceutical Society

Medical biochemistry (synonyms: clinical chemistry or clinical biochemistry) in the terms of professional and scientific discipline, stems from and/or has developed along with the natural sciences and its influences (mathematics, physics, chemistry and biochemistry) and medical sciences as well (physiology, genetics, cell biology). As a scientific discipline, medical biochemistry studies metabolic processes of physiological and pathological changes with humans and animals. Applying analytical chemistry's and biochemistry's techniques enables medical biochemists to gain plenty of information related to diagnosis and prognosis which serve physicians to asses the gravity of illness and prescribe healing therapy. Therefore medical biochemistry is an integral part of modern medicine. This discipline was dubbed various, often confusing names such as pathology, physiology, clinical biology, clinical pathology, chemical pathology, clinical biochemistry, medical biochemistry, clinical chemistry and laboratory medicine, all depending on place of origin. The official, internationally accepted name - clinical chemistry, was mentioned for the first time in 1912 by Johan Scherer, who described his laboratory as Clinical Chemistry Laboratory (Klinisch Chemische Laboratorium) in the hospital Julius in Wurzburg in Germany. After creating national societies of clinical chemists, Professor Earl J. King of Royal Postgraduate Medical School from London incited an initiative to unite national societies into the organization with worldwide character - it was the International Association of Clinical Biochemists, monitored by the International Union for Pure and Applied Chemistry (IUPAC). On 24 July 1952 in Paris, a Second International Congress of Biochemistry was held. A year later, in Stockholm, the name of a newly formed association was altered into International Federation of Clinical Chemistry, which was officially accepted in 1955 in Brussels. Today this federation-s name is International Federation for Clinical Chemistry and Laboratory Medicine (IFCC). Right after the World War II our medical biochemists began to gather within their expert societies. Even before 1950 Pharmaceutical Society of Serbia hosted laboratory experts among whom the most active were Prof. Dr. Aleksandar Damanski for bromatology, Prof. Dr. Momcilo Mokranjac for toxicology and Docent Dr. Pavle Trpinac for biochemistry. When the Managing Board of the Pharmaceutical Society of National Republic of Serbia held its session on 22 December 1950, an issue was raised with reference to creation of a Section that would gather together the laboratory experts. Section for Sanitary Chemistry, combining all three profiles of laboratory staff, i.e. medical biochemists, sanitary chemists and toxicologists, was founded on 1st of January 1951. On 15 May 1955, during the sixth plenum of the Society of Pharmaceutical Societies of Yugoslavia (SFRY) held in Split, the decision was passed to set up a Section for Medical Biochemistry in SFDJ. The Section for Medical Biochemistry in SFDJ was renamed into Society for Medical Biochemistry of SFDJ based on the decision passed during the 16th plenum of SFDJ, held on 15 May 1965 in Banja Luka. Pursuant to the decision passed by SMBY on 6 April 1995 and based on the historic data, 15 May was declared as being the official Day of the Society of Medical Biochemists of Yugoslavia. The purpose of YuSMB (currently SMBSCG) is to gather medical biochemists who would develop and enhance all the branches of medical biochemistry in health industry. Its tasks are as following: to standardize operations in clinical-biochemical laboratories, education of young biochemists on all levels, encouraging scientific research, setting up of working norms and implementation, execution and abiding by the ethics codices with health workers. SMBSCG is to promote the systemized standards in the field of medical biochemistry with the relevant federal and republican institutions. SMBSCG is to enable exchange of experiences of its members with the members of affiliate associations in the country and abroad. .

Mangankonzentrationen im Vollblut, Plasma und Serum adulter Warmblutpferde an 3 Standorten in Deutschland

2021 ◽  
Vol 49 (04) ◽  
pp. 234-246
Author(s):  
Elena Theiner ◽  
Corinna Weber ◽  
Elisabeth Müller ◽  
Monica Venner ◽  
Ingrid Vervuert
Keyword(s):  
Clinical Chemistry ◽  
Laboratory Medicine ◽  
International Federation ◽  
Klinische Relevanz ◽  
Icp Ms

Zusammenfassung Ziel Etablierung von Referenzintervallen für Mangan (Mn) im Serum, Plasma und Vollblut bei adulten, gesunden Warmblutpferden mit bekannter Mn-Aufnahme und Vergleich von 2 analytischen Methoden der Mn-Bestimmung im Blut. Material und Methoden Zwischen Mai 2018 und November 2019 erfolgte auf 3 Gestüten bei 270 gesunden Pferden im Alter von 3–25 Jahren eine einmalige Blutprobenentnahme. In Vollblut, Plasma (Antikoagulans jeweils Lithium-Heparin [LH]) und Serum wurden die Mn-Konzentrationen mittels Massenspektrometrie mit induktiv gekoppeltem Plasma (ICP-MS) sowie mittels Atomabsorptionsspektrometrie (AAS) bestimmt. Die Referenzintervalle für jedes Substrat wurden nach den Empfehlungen der International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) und des Clinical and Laboratory Standards Institute (CLSI) berechnet (Bereich zwischen 2,5- und 97,5-Perzentil der analysierten Mn-Blutkonzentration). Zeitgleich mit der Blutprobenentnahme wurden repräsentative Futterproben entnommen, um den Mn-Gehalt der korrespondierenden Fütterung zu bestimmen. Ergebnisse Die Pferde zeigten im Vollblut mit einer medianen Mn-Konzentration von 12,4 µg/l (Referenzintervall: 4,99–25,1 µg/l [AAS]; 5,99–25,3 µg/l [ICP-MS]) signifikant höhere Mn-Konzentrationen (p < 0,0001) als im korrespondierenden Serum (Median: 1,65 µg/l, Referenzintervall: 0,60–3,50 µg/l [AAS]; 1,11–2,96 µg/l [ICP-MS]) oder LH-Plasma (Median: 1,35 µg/l, Referenzintervall: 0,22–2,68 µg/l [AAS]; 0,59–2,45 µg/l [ICP-MS]). Im Methodenvergleich ergaben sich für LH-Plasma und Serum zwischen der AAS und der ICP-MS statistisch signifikante Abweichungen in den Mn-Bestimmungen, wohingegen sie für das Vollblut vergleichbare Ergebnisse lieferten. Schlussfolgerung und klinische Relevanz Vollblut weist durchschnittlich 10-fach höhere Mn-Konzentrationen auf als Serum oder LH-Plasma. Bei der Bewertung von Mn-Konzentrationen im Blut muss daher berücksichtigt werden, welches Probenmaterial analysiert wurde und welche Methode zur Anwendung kam, da in Serum und Plasma zwischen AAS und ICP-MS relevante Unterschiede auftreten können.

Sign in / Sign up

Export Citation Format

Share Document